Adcock Ingram Holdings reported ZAR541.46M in EBIT for its fiscal semester ending in June of 2023.


Ebit Change Date
Adcock Ingram Holdings ZAR 541.46M 52.57M Jun/2023
Alaunos Therapeutics USD -7949000 715K Dec/2023
Aspen Pharmacare ZAR 4.78B 534M Dec/2024
Avita Medical AUD -10272000 22.56M Dec/2024
Dianthus Therapeutics USD -34927000 3.01M Jun/2025
Ionis Pharmaceuticals USD 144.78M 290.78M Jun/2025
IQVIA Holdings USD 556M 187M Jun/2025
Life Healthcare ZAR 2.07B 922M Sep/2024
Moderna USD -817000000 146M Jun/2025
Netcare ZAR 1.66B 203M Jun/2023
Organon & Co USD 360M 135M Jun/2025
Revvity USD 90.76M 79.15M Jun/2025
Tectonic Therapeutic USD -22332000 8.34M Jun/2025
Viatris USD 185.4M 628M Jun/2025
Xeris Pharmaceuticals USD 5.43M 3.75M Jun/2025